AIFC

AIFC (operating as ALT5 Sigma) is not the commodity broker its SIC code implies — it is a sub-$1 penny stock that, per the MD&A, closed a $1.5B registered direct offering and private placement in August 2025 led by World Liberty Financial to build a 'WLFI Treasury Strategy,' acquiring a large position in WLFI, the native governance token of a nascent DeFi ecosystem. That single transaction explains nearly every headline number: total assets exploding +1510% to $1.22B, stockholders' equity +9152% to $1.15B, and shares outstanding +690% to 127M. The 'balance-sheet strength' (liabilities/equity of 0.05x) is an illusion — equity is dominated by a volatile, illiquid governance token marked to market, and the -$345M net loss (net margin -1387%) reflects exactly that kind of mark-to-market and the accumulated deficit of -$403M in retained earnings.

The operating business underneath is thin and erratic. Revenue grew 109% to $24.8M, but the five-year history is incoherent — $33.9M, then $0, then $0, then $11.9M, then $24.8M — which is the opposite of the durable, repeatable growth that would justify a position. Operating income is -$22.9M (operating margin -92%), operating cash flow is -$7.16M, and the company holds just $6.22M of cash against $51.4M of current liabilities and only $29.5M of current assets — a working-capital deficit. The biotech segment has been discontinued. So the equity story is now almost entirely a leveraged bet on the price of one crypto governance token tied to the World Liberty Financial / USD1 ecosystem, funded by enormous dilution.